La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
NuVasive Salute del bilancio
Salute finanziaria criteri di controllo 3/6
NuVasive has a total shareholder equity of $892.5M and total debt of $795.5M, which brings its debt-to-equity ratio to 89.1%. Its total assets and total liabilities are $2.1B and $1.2B respectively. NuVasive's EBIT is $82.6M making its interest coverage ratio 6.1. It has cash and short-term investments of $80.7M.
Informazioni chiave
89.1%
Rapporto debito/patrimonio netto
US$795.54m
Debito
| Indice di copertura degli interessi | 6.1x |
| Contanti | US$80.72m |
| Patrimonio netto | US$892.54m |
| Totale passività | US$1.20b |
| Totale attività | US$2.09b |
Aggiornamenti recenti sulla salute finanziaria
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Apr 18
These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well
Nov 13Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Aug 11NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Apr 20NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Nov 11Recent updates
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Apr 18What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?
Jan 24NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price
Dec 31Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Dec 05These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well
Nov 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Sep 22Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Sep 01NuVasive Likely Undervalued, But It's Hard To Find Catalysts
Aug 17Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Aug 11NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M
Aug 03NuVasive: Industry Tailwinds More Than Fairly Priced
Jun 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jun 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
May 11NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Apr 20At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?
Mar 30NuVasive's Turnaround Story Needs A Boost From Better Results
Mar 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
Dec 28Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?
Dec 02NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Nov 11NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate
Oct 21Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital
Sep 29At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?
Aug 18NuVasive Still Getting No Love With COVID-19 And Competitive Worries
Aug 12Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Jul 27Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?
Jun 17Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital
May 30Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All
May 12Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Mar 30Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?
Mar 09Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares
Feb 16
A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jan 26NuVasive stock gains on study results of its X360 surgery approach
Jan 06What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 05Analisi della posizione finanziaria
Passività a breve termine: NUVA's short term assets ($728.3M) exceed its short term liabilities ($582.6M).
Passività a lungo termine: NUVA's short term assets ($728.3M) exceed its long term liabilities ($614.4M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: NUVA's net debt to equity ratio (80.1%) is considered high.
Riduzione del debito: NUVA's debt to equity ratio has increased from 80.6% to 89.1% over the past 5 years.
Copertura del debito: NUVA's debt is not well covered by operating cash flow (17.5%).
Copertura degli interessi: NUVA's interest payments on its debt are well covered by EBIT (6.1x coverage).